Historical Valuation
Resmed Inc (RMD) is now in the Fair zone, suggesting that its current forward PE ratio of 21.84 is considered Fairly compared with the five-year average of 29.26. The fair price of Resmed Inc (RMD) is between 234.33 to 407.02 according to relative valuation methord.
Relative Value
Fair Zone
234.33-407.02
Current Price：250.92
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Resmed Inc (RMD) has a current Price-to-Book (P/B) ratio of 5.84. Compared to its 3-year average P/B ratio of 6.29 , the current P/B ratio is approximately -7.14% higher. Relative to its 5-year average P/B ratio of 8.17, the current P/B ratio is about -28.56% higher. Resmed Inc (RMD) has a Forward Free Cash Flow (FCF) yield of approximately 4.96%. Compared to its 3-year average FCF yield of 3.38%, the current FCF yield is approximately 46.66% lower. Relative to its 5-year average FCF yield of 2.61% , the current FCF yield is about 89.67% lower.
P/B
Median3y
6.29
Median5y
8.17
FCF Yield
Median3y
3.38
Median5y
2.61
Competitors Valuation Multiple
AI Analysis for RMD
The average P/S ratio for RMD competitors is 3.99, providing a benchmark for relative valuation. Resmed Inc Corp (RMD.N) exhibits a P/S ratio of 6.26, which is 56.97% above the industry average. Given its robust revenue growth of 9.07%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for RMD
1Y
3Y
5Y
Market capitalization of RMD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of RMD in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is RMD currently overvalued or undervalued?
Resmed Inc (RMD) is now in the Fair zone, suggesting that its current forward PE ratio of 21.84 is considered Fairly compared with the five-year average of 29.26. The fair price of Resmed Inc (RMD) is between 234.33 to 407.02 according to relative valuation methord.
What is Resmed Inc (RMD) fair value?
RMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Resmed Inc (RMD) is between 234.33 to 407.02 according to relative valuation methord.
How does RMD's valuation metrics compare to the industry average?
The average P/S ratio for RMD's competitors is 3.99, providing a benchmark for relative valuation. Resmed Inc Corp (RMD) exhibits a P/S ratio of 6.26, which is 56.97% above the industry average. Given its robust revenue growth of 9.07%, this premium appears unsustainable.
What is the current P/B ratio for Resmed Inc (RMD) as of Jan 09 2026?
As of Jan 09 2026, Resmed Inc (RMD) has a P/B ratio of 5.84. This indicates that the market values RMD at 5.84 times its book value.
What is the current FCF Yield for Resmed Inc (RMD) as of Jan 09 2026?
As of Jan 09 2026, Resmed Inc (RMD) has a FCF Yield of 4.96%. This means that for every dollar of Resmed Inc’s market capitalization, the company generates 4.96 cents in free cash flow.
What is the current Forward P/E ratio for Resmed Inc (RMD) as of Jan 09 2026?
As of Jan 09 2026, Resmed Inc (RMD) has a Forward P/E ratio of 21.84. This means the market is willing to pay $21.84 for every dollar of Resmed Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Resmed Inc (RMD) as of Jan 09 2026?
As of Jan 09 2026, Resmed Inc (RMD) has a Forward P/S ratio of 6.26. This means the market is valuing RMD at $6.26 for every dollar of expected revenue over the next 12 months.